emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Dechra Pharmaceuticals / Genera

No EMAT : 83260
Announced Date : 18/09/2015
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Dechra Pharmaceuticals

Target : Genera
Country : Croatia
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Genera d.d. is the oldest and largest manufacturer of animal health products in the Republic of Croatia. > Operates three main divisions: Animal Health, which represents the majority of revenue;...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
10/02/2015 Fund raising led by Cap Innov'Est (Alsace Capital) Inoviem Scientific France * 82827
23/02/2015 Private Group led by LBC Synexus United Kingdom ** 82819

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report